Table 3.
ARI negative –/n (%) | ARI positive +/n (%) | COR (95% CI) | p-value | AOR (95% CI) | ||
---|---|---|---|---|---|---|
Time from first Symptoms | 1–2 days | 3/26 (11.5) | 23/26 (88.5) | |||
3–5 days | 5/40 (12.5) | 35/40 (87.5) | 0.91 (0.20–4.20) | 0.91 | – | |
6–7 days | 19/63 (30.2) | 44/63 (69.8) | 0.30 (0.08–1.13) | 0.08 | – | |
Nasal obstruction | Absent | 6/10 (60.0) | 4/10 (40.0) | |||
Present | 21/119 (17.6) | 98/119 (82.4) | 7.00 (1.82–27.00) | <0.01 | 6.60 (1.65–26.39)** | |
Chest Pain | Absent | 24/125 (19.2) | 101/125 (80.8) | |||
Present | 3/4 (75.0) | 1/4 (25.0) | 0.08 (0.01–0.80) | 0.03 | 0.09 (0.01–0.96)* | |
Conjunctivitis | Absent | 23/123 (18.7) | 100/123 (81.3) | |||
Present | 4/6 (66.7) | 2/6 (33.3) | 0.12 (0.02–0.67) | 0.02 | – | |
Cough | Absent | 6/17 (35.3) | 11/17 (64.7) | |||
Present | 21/112 (18.8) | 91/112 (81.3) | 2.36 (0.79–7.12) | 0.13 | – | |
Nu. of Typical Symptoms ARI | 1 | 4/9 (44.4) | 5/9 (55.6) | 1.04 (0.60–1.79) | 0.89 | – |
2 | 7/25 (28.0) | 18/25 (72.0) | ||||
3 | 12/87 (13.8) | 75/87 (86.2) | ||||
4 | 2/6 (33.3) | 4/6 (66.7) | ||||
5 | 1/1 (100.0) | 0/1 (0.0) | ||||
7 | 1/1 (100.0) | 0/1 (0.0) |
COR, crude odds ratio; AOR, adjusted odds ratio; OR, odds ratio; CI, confidence interval.
p < 0.05;
p < 0.01.